Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Thomas Jefferson University
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects with episodic or transformed migraine age 18to 80 years old.
Subjects must have unilateral migraine headache and trigeminal distribution brush allodynia at the time of injection.
Subjects must be able to consent or assent to the study.
You may not be if
Subjects who in their own or in the investigator's opinion are unable to report the severity of four symptoms (pin sharpness to determine efficacy of nerve block, headache severity, photophobia severity and allodynia severity), every 30 seconds for 5 minutes post injection;
Subjects with skull defect, or history of injury to the area of the GON.
Subjects with prior adverse reaction to GON block, lidocaine or marcaine.
